Caseware UK (AP4) 2024.0.164 2024.0.164 2024-09-302024-09-30true2023-10-01falseProperty investment22trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 11148974 2023-10-01 2024-09-30 11148974 2022-10-01 2023-09-30 11148974 2024-09-30 11148974 2023-09-30 11148974 c:Director1 2023-10-01 2024-09-30 11148974 d:FurnitureFittings 2023-10-01 2024-09-30 11148974 d:FurnitureFittings 2024-09-30 11148974 d:FurnitureFittings 2023-09-30 11148974 d:CurrentFinancialInstruments 2024-09-30 11148974 d:CurrentFinancialInstruments 2023-09-30 11148974 d:CurrentFinancialInstruments d:WithinOneYear 2024-09-30 11148974 d:CurrentFinancialInstruments d:WithinOneYear 2023-09-30 11148974 d:ShareCapital 2024-09-30 11148974 d:ShareCapital 2023-09-30 11148974 d:RetainedEarningsAccumulatedLosses 2024-09-30 11148974 d:RetainedEarningsAccumulatedLosses 2023-09-30 11148974 c:FRS102 2023-10-01 2024-09-30 11148974 c:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 11148974 c:FullAccounts 2023-10-01 2024-09-30 11148974 c:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 11148974 2 2023-10-01 2024-09-30 11148974 6 2023-10-01 2024-09-30 11148974 d:Right-of-useInvestmentProperty 2023-10-01 2024-09-30 11148974 d:Right-of-useInvestmentProperty 2024-09-30 11148974 d:Right-of-useInvestmentProperty 2023-09-30 11148974 e:PoundSterling 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure

Registered number: 11148974










LONDON PLASTIC SURGERY HOLDINGS LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 SEPTEMBER 2024

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
REGISTERED NUMBER: 11148974

BALANCE SHEET
AS AT 30 SEPTEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 5 
100
100

Investment property
 6 
1,151,540
1,101,649

  
1,151,640
1,101,749

Current assets
  

Debtors: amounts falling due within one year
 7 
7,150
10,662

Cash at bank and in hand
 8 
133,108
192,401

  
140,258
203,063

Creditors: amounts falling due within one year
 9 
(146,579)
(212,615)

Net current liabilities
  
 
 
(6,321)
 
 
(9,552)

Total assets less current liabilities
  
1,145,319
1,092,197

  

Net assets
  
1,145,319
1,092,197


Capital and reserves
  

Called up share capital 
  
200
200

Profit and loss account
  
1,145,119
1,091,997

  
1,145,319
1,092,197

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




D Fallahdar
Director
Page 1

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
REGISTERED NUMBER: 11148974
    
BALANCE SHEET (CONTINUED)
AS AT 30 SEPTEMBER 2024


Date: 27 June 2025

The notes on pages 3 to 10 form part of these financial statements.

Page 2

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

1.


General information

The company is a private company limited by shares, and is incorporated in England and Wales. The address of its registered office is 14th Floor, 33 Cavendish Square,London, W1G 0PW.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The accounts have been prepared on a going concern basis. The directors are confident that activity levels will allow the company to meet its liabilities as they fall due.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

Page 3

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.6

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


 
2.7

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Fixtures and fittings
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.8

Investment property

Investment property is carried at fair value determined annually by the directors and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.

 
2.9

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 4

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
 
2.13

Financial instruments


The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due within the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
Page 5

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)


2.13
Financial instruments (continued)


Page 6

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

2.Accounting policies (continued)


2.13
Financial instruments (continued)


Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).







Page 7

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

4.


Tangible fixed assets





Fixtures and fittings

£



Cost or valuation


At 1 October 2023
5,097



At 30 September 2024

5,097



Depreciation


At 1 October 2023
5,097



At 30 September 2024

5,097



Net book value



At 30 September 2024
-



At 30 September 2023
-


5.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 October 2023
100



At 30 September 2024
100




Page 8

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

6.


Investment property


Property held for develop-ment

£



Valuation


At 1 October 2023
1,101,649


Additions at cost
49,891



At 30 September 2024
1,151,540





At 30 September 2024



If the Investment properties had been accounted for under the historic cost accounting rules, the properties would have been measured as follows:

2024
2023
£
£


Historic cost
1,151,540
1,101,649


7.


Debtors

2024
2023
£
£


Amounts owed by group undertakings
4,165
7,176

Prepayments and accrued income
2,985
3,486

7,150
10,662



8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
133,108
192,401


Page 9

 
LONDON PLASTIC SURGERY HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024

9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Corporation tax
6,175
338

Other creditors
113,030
184,968

Accruals and deferred income
27,374
27,309

146,579
212,615



10.


Related party transactions

Included in other creditors is an amount of £113,030 (2023: £184,968) owed to a director. This loan is unsecured and interest free.

 
Page 10